Johnson & Johnson

NYSE: JNJ
$164.16
-$0.66 (-0.4%)
Closing Price on September 20, 2024

JNJ Articles

Johnson & Johnson is expected to report its second-quarter financial results Tuesday morning before the markets open.
Earnings season for the second quarter of the calendar year has kicked off, and 24/7 Wall St. has put together a preview of some of the Dow Jones companies that are reporting their quarterly results...
With the Greek debacle throwing some very cold water on the market, it makes sense for investors to use cash wisely and scale into these stocks.
24/7 Wall St. has collected several big FDA decisions coming up on the calendar for the month of July and added some color.
thinkstockJune 18, 2015: Markets opened higher on Thursday based on the FOMC’s decision to leave interest rates alone and generally good economic data reported early this morning. A weaker dollar...
Older Americans, in many cases, have lost their tolerance for financial risk and they want to protect the size of the nest eggs they have put aside for retirement.
Credit Suisse has updated its autoimmune market model and it sees implications for all of the large cap U.S. pharmaceutical companies in its coverage.
The jump in market volatility did not deter executives and 10% shareholders this week, and insider buying stayed solid.
It turns out that Buffett has five public stocks that used to be far larger stakes or which seem like token positions.
thinkstockMay 22 2015: Markets opened mixed on Friday on a day that was tough on blue chips. The energy sector slipped on a stronger dollar and lower crude oil prices, even though crude posted a...
Back in November of 2010, 24/7 Wall St. first issued a list of stocks to own for the next decade. Even long-term investors need to assess their portfolios from time to time.
Johnson & Johnson has been working on its pharmaceuticals pipeline for a while, and plans on continuing to do so.
thinkstockMay 18, 2015: Markets opened lower on Monday, but the financial and healthcare sectors led the indexes above the break-even line by mid-morning. The gains are modest and trading volume was...
It turns out that hedge fund Bridgewater Associates and founder Ray Dalio have made some changes since the end of 2014.
UBS has added one of the world's largest oilfield services companies to its Dividend Ruler portfolio. Top dividend stocks continue to be outstanding holdings in long-term growth and income portfolios.